日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Coramitug, a Humanized Monoclonal Antibody for the Treatment of Transthyretin Amyloid Cardiomyopathy: A Phase 2, Randomized, Multicenter, Double-Blind, Placebo-Controlled Trial

Coramitug,一种用于治疗转甲状腺素蛋白淀粉样变性心肌病的人源化单克隆抗体:一项 II 期随机、多中心、双盲、安慰剂对照试验

Fontana, Marianna; García-Pavía, Pablo; Grogan, Martha; Shah, Sanjiv J; Engelmann, Mads D M; Hovingh, G Kees; Kristen, Arnt V; Lim-Watson, Michelle Z; Malling, Brian; Kar, Soumitra; Revanna, Manjunatha; Sarswat, Nitasha; Tsujita, Kenichi; Alexander, Kevin M; Maurer, Mathew S

Neutralizing human monoclonal antibodies to poliovirus map to the receptor binding site

针对脊髓灰质炎病毒的中和性人类单克隆抗体定位于受体结合位点

Waddey, Benjamin T; Charnesky, Andrew J; Faust, Julia E; DiNunno, Nadia M; Puligedda, Rama Devudu; Cho, Sung Hyun; Bator, Carol M; Dong, Steven D; Mahmood, Kutub; Chumakov, Konstantin M; Dessain, Scott K; Hafenstein, Susan L

XA-Novo: high-throughput mass spectrometry-based de novo sequencing technology for monoclonal antibodies and antibody mixtures

XA-Novo:基于高通量质谱的单克隆抗体和抗体混合物从头测序技术

Xiong, Yueting; Jiang, Wenbin; Xiao, Jin; Bu, Qingfang; Wang, Jingyi; Jiang, Zhenjian; Luo, Ling; Chen, Xiaoqing; Qiu, Yijie; Wu, Yangtao; Liu, Fan; Yu, Rongshan; Xia, Ningshao; Yuan, Quan

Development of a potent monoclonal antibody for treatment of human metapneumovirus infections.

开发一种强效单克隆抗体用于治疗人类偏肺病毒感染。

Harris Evelyn D, McGovern Morgan, Pernikoff Sara, Ikeda Ren, Kipnis Lea, Hannon William, Sobolik Elizabeth B, Gray Matthew, Greninger Alexander L, He Sijia, Chin Chen-Ni, Fu Tong-Ming, Pancera Marie, Boonyaratanakornkit Jim

Erratum to: Intracranial administration of anti-PD-1 and anti-CTLA-4 immune checkpoint-blocking monoclonal antibodies in patients with recurrent high-grade glioma

更正:颅内注射抗PD-1和抗CTLA-4免疫检查点阻断单克隆抗体治疗复发性高级别胶质瘤患者

A novel recombinant anti-cluster of differentiation 20 humanized monoclonal antibody (B001) for the treatment of neuromyelitis optica spectrum disorder: a phase 1, multicenter randomized, double-blind trial

一种新型重组抗分化簇20人源化单克隆抗体(B001)用于治疗视神经脊髓炎谱系障碍:一项I期多中心随机双盲试验

Chen, Yi-Lun; Lai, Shih-Fan; Yang, Wen-Chi; Lu, Shao-Lun; Tsuang, Fon-Yih; Xiao, Fu-Ren; Lin, Wei-Hsin; Chen, Ya-Fang; Chang, Chin-Hao; Hsu, Feng-Ming; Jia, Dongmei; Wang, Huabing; Jiang, Wei; Shen, Yi; Guo, Jun; Zhao, Daidi; Zhang, Meini; Meng, Huaxing; Xue, Huiru; Song, Yunxing; Yao, Qin; Xie, Ning; Zhang, Chao

Discovery and preclinical evaluation of monoclonal antibodies and bispecific engagers targeting the NKG2A inhibitory receptor

针对NKG2A抑制性受体的单克隆抗体和双特异性衔接器的发现和临床前评估

Shin, Seungmin; Kim, Yae-Jin; Macatangay, Bernard J C; Cyktor, Joshua C; Hines, Margaret G; Sun, Ze-Yu; Chen, Kong; Mellors, John W; Dimitrov, Dimiter S; Li, Wei; Baek, Du-San

A new immunotherapy ROR: Proximal ROR1 domain targeting breast cancer via monoclonal antibodies and CAR NK cells

一种新型免疫疗法 ROR:通过单克隆抗体和 CAR NK 细胞靶向治疗乳腺癌的近端 ROR1 结构域

Fehniger, Todd A

Use of anti-amyloid-β monoclonal antibodies in persons with Down syndrome Alzheimer's disease

在唐氏综合征合并阿尔茨海默病患者中使用抗β-淀粉样蛋白单克隆抗体

Farrell, Clíona; Saini, Fedal; Beidas, Mona M; Ryan, Natalie S; Strydom, Andre; Wiseman, Frances K

Preclinical characterisation of the protective capacity of an anti-nucleoprotein hRSV monoclonal antibody.

抗核蛋白 hRSV 单克隆抗体的保护能力的临床前表征。

Farías Mónica A, Andrade Catalina A, Loaiza Ricardo A, Rodríguez-Guilarte Linmar, Muñoz José T, Pereira-Sánchez Patricia, Muñoz-Durango Natalia, Pizarro-Ortega Magdalena S, Diethelm-Varela Benjamín, Pereira-Serrano Alejandra, Ramírez Robinson A, Chávez José L, Bohmwald Karen, Soto Jorge A, González Pablo A, Bueno Susan M, Kalergis Alexis M